These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 24082000)

  • 1. Nonmedical vaccine exemptions and pertussis in California, 2010.
    Atwell JE; Van Otterloo J; Zipprich J; Winter K; Harriman K; Salmon DA; Halsey NA; Omer SB
    Pediatrics; 2013 Oct; 132(4):624-30. PubMed ID: 24082000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geographic clustering of nonmedical exemptions to school immunization requirements and associations with geographic clustering of pertussis.
    Omer SB; Enger KS; Moulton LH; Halsey NA; Stokley S; Salmon DA
    Am J Epidemiol; 2008 Dec; 168(12):1389-96. PubMed ID: 18922998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geospatial analysis of nonmedical vaccine exemptions and pertussis outbreaks in the United States.
    Aloe C; Kulldorff M; Bloom BR
    Proc Natl Acad Sci U S A; 2017 Jul; 114(27):7101-7105. PubMed ID: 28634290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonmedical exemptions to school immunization requirements: secular trends and association of state policies with pertussis incidence.
    Omer SB; Pan WK; Halsey NA; Stokley S; Moulton LH; Navar AM; Pierce M; Salmon DA
    JAMA; 2006 Oct; 296(14):1757-63. PubMed ID: 17032989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examining the spatiotemporal evolution of vaccine refusal: nonmedical exemptions from vaccination in California, 2000-2013.
    Delamater PL; Leslie TF; Yang YT
    BMC Public Health; 2018 Apr; 18(1):458. PubMed ID: 29688861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Vaccine Refusal and Vaccine-Preventable Diseases in the United States: A Review of Measles and Pertussis.
    Phadke VK; Bednarczyk RA; Salmon DA; Omer SB
    JAMA; 2016 Mar; 315(11):1149-58. PubMed ID: 26978210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak.
    Witt MA; Katz PH; Witt DJ
    Clin Infect Dis; 2012 Jun; 54(12):1730-5. PubMed ID: 22423127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of pertussis vaccination and duration of immunity.
    Schwartz KL; Kwong JC; Deeks SL; Campitelli MA; Jamieson FB; Marchand-Austin A; Stukel TA; Rosella L; Daneman N; Bolotin S; Drews SJ; Rilkoff H; Crowcroft NS
    CMAJ; 2016 Nov; 188(16):E399-E406. PubMed ID: 27672225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. California pertussis epidemic, 2010.
    Winter K; Harriman K; Zipprich J; Schechter R; Talarico J; Watt J; Chavez G
    J Pediatr; 2012 Dec; 161(6):1091-6. PubMed ID: 22819634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Waning protection after fifth dose of acellular pertussis vaccine in children.
    Klein NP; Bartlett J; Rowhani-Rahbar A; Fireman B; Baxter R
    N Engl J Med; 2012 Sep; 367(11):1012-9. PubMed ID: 22970945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Religious exemptions for immunization and risk of pertussis in New York State, 2000-2011.
    Imdad A; Tserenpuntsag B; Blog DS; Halsey NA; Easton DE; Shaw J
    Pediatrics; 2013 Jul; 132(1):37-43. PubMed ID: 23733795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case-control study of vaccination history in relation to pertussis risk during an outbreak among school students.
    Khan FN; Lin M; Hinkle CJ; Franklin P; Luther R; Woodruff F; Henson K; Lukenbill M; Gutierrez M; Zhu BP
    Pediatr Infect Dis J; 2006 Dec; 25(12):1132-6. PubMed ID: 17133158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of pertussis vaccines for adolescents and adults: case-control study.
    Baxter R; Bartlett J; Rowhani-Rahbar A; Fireman B; Klein NP
    BMJ; 2013 Jul; 347():f4249. PubMed ID: 23873919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-cell and acellular pertussis vaccination programs and rates of pertussis among infants and young children.
    Vickers D; Ross AG; Mainar-Jaime RC; Neudorf C; Shah S
    CMAJ; 2006 Nov; 175(10):1213-7. PubMed ID: 17098950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.
    Gustafsson L; Hessel L; Storsaeter J; Olin P
    Pediatrics; 2006 Sep; 118(3):978-84. PubMed ID: 16950988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parental refusal of pertussis vaccination is associated with an increased risk of pertussis infection in children.
    Glanz JM; McClure DL; Magid DJ; Daley MF; France EK; Salmon DA; Hambidge SJ
    Pediatrics; 2009 Jun; 123(6):1446-51. PubMed ID: 19482753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy of the Japanese acellular pertussis vaccine after intrafamiliar exposure to pertussis patients.
    Isomura S; Suzuki S; Sato Y
    Dev Biol Stand; 1985; 61():531-7. PubMed ID: 3914964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers.
    Klein NP; Bartlett J; Fireman B; Rowhani-Rahbar A; Baxter R
    Pediatrics; 2013 Jun; 131(6):e1716-22. PubMed ID: 23690518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pertussis in 1997].
    Tomaszunas-Błaszczyk J
    Przegl Epidemiol; 1999; 53(1-2):23-32. PubMed ID: 10402846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.